Opinions in hypertension. ARBs and risk of cancer: international and South African expert comment

Cardiovasc J Afr. 2010 Nov-Dec;21(6):338-41.

Authors

C Lombard¹, A Nosworthy, J Albers

Affiliation

¹ Biostatistics Unit, Medical Research Council.

PMID: 21135984
PMCID: PMC6107719

No abstract available

MeSH terms

Angiotensin II Type 1 Receptor Blockers / adverse effects*
Antihypertensive Agents / adverse effects*
Evidence-Based Medicine
Humans
Hypertension / drug therapy*
Meta-Analysis as Topic
Neoplasms / chemically induced*
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors

Substances

Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents